Please assess the completion status of the following clinical trial:

Trial Title: Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and Females~* Age 6 months to 17 years~* Scheduled for elective scoliosis surgery or major craniofacial surgery~* Written informed consent has been obtained~* Intraoperative hypofibrinogenemia according to definition of treatment groups~Exclusion Criteria:~* Preexisting congenital or acquired coagulation disorder~* Medical history of estimated increased bleeding tendency~* Ongoing coagulation therapy~* Clinical signs or diagnosis of acute thromboembolism~* Intolerance of study drug~* Participation at another clinical trial~* Pregnant or lactating women

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Fibrinogen if FibTEM < 8 mm (Type: ACTIVE_COMPARATOR): Administration of fibrinogen concentrate if ROTEM FibTEM revealed MCF \< 8 mm
- Fibrinogen if FibTEM < 13 mm (Type: EXPERIMENTAL): Administration of fibrinogen concentrate if ROTEM FibTEM revealed MCF \< 13 mm

Based on this trial design, predict the completion outcome and termination type (if applicable).